University of California San Francisco
Give to UCSF<p>Elizabeth Boyd, UCSF’s associate vice chancellor, Ethics and Compliance, has been named the UCSF Research Integrity Officer (RIO).</p>
<p>Peter Barnett may be the most physically active man in Mill Valley, California, thanks to UCSF's specialized cardiac care which is essential to the growing number of adults who need ongoing treatment for heart defects they've had since birth.</p>
<p>UCSF's occasional series profiling great managers continues with a focus on Kevin Souza, who began 25 years ago as a manager of a basic science research lab in endocrinology.</p>
<p>UCSF’s Patricia Dennehy, director of the nurse-managed Glide Health Services center, is among five Californians to receive the 2012 James Irvine Foundation Leadership Awards today for applying proven, innovative approaches to some of the state’s most difficult problems.</p>
<p>Randy Daron, PsyD, recently appointed UCSF Ombuds, finds himself frequently explaining the meaning of the word “Ombuds” to members of the UCSF community.</p>
<p>Pediatric dentist Ling Zhan, an assistant professor in the UCSF School of Dentistry, is working to better understand the risk factors for cavities, and balance these with proven prevention measures, which has proven to be successful by adults.</p>
<p>The Second Annual Florence Stroud Black History Month Conference Series presents a special symposium, "<em>Joining Forces: Answering the Call to Serve Military Families.</em>'' The event will focus on the myriad challenges facing members of the military and their families, including post-traumatic stress disorder, suicide, and other psychological issues.</p>
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and UCSF.
<p>Scientists at the San Francisco VA Medical Center and the University of California, San Francisco have published a study showing that one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, tenofovir, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time. See accompanying news release, <a href="http://ucsf.edu/news/2012/02/11508/tenofovir-leading-hiv-medication-linked-risk-kidney-damage">Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage</a>.</p>